RGT-075

N/A

Report date: 2024/02/27 20:00:31
NME

Base Information

Drug NameRGT-075
Drug Alias NameRGT001-075RGT-075
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQILU Regor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRegor Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A